Skip to Content
Merck
  • Label-Free Detection and Characterization of Heparin-Induced Thrombocytopenia (HIT)-like Antibodies.

Label-Free Detection and Characterization of Heparin-Induced Thrombocytopenia (HIT)-like Antibodies.

ACS omega (2021-10-19)
Nida Zaman Khan, Li-Yu Chen, Annerose Lindenbauer, Uwe Pliquett, Holger Rothe, Thi-Huong Nguyen
ABSTRACT

Heparin-induced thrombocytopenia (HIT) antibodies (Abs) can mediate and activate blood cells, forming blood clots. To detect HIT Abs, immunological assays with high sensitivity (≥95%) and fast response are widely used, but only about 50% of these tests are accurate as non-HIT Abs also bind to the same antigens. We aim to develop biosensor-based electrical detection to better differentiate HIT-like from non-HIT-like Abs. As a proof of principle, we tested with two types of commercially available monoclonal Abs including KKO (inducing HIT) and RTO (noninducing HIT). Platelet factor 4/Heparin antigens were immobilized on gold electrodes, and binding of antibodies on the chips was detected based on the change in the charge transfer resistance (R ct). Binding of KKO on sensors yielded a significantly lower charge transfer resistance than that of RTO. Bound antibodies and their binding characteristics on the sensors were confirmed and characterized by complementary techniques. Analysis of thermal kinetics showed that RTO bonds are more stable than those of KKO, whereas KKO exhibited a higher negative ζ potential than RTO. These different characteristics made it possible to electrically differentiate these two types of antibodies. Our study opens a new avenue for the development of sensors for better detection of pathogenic Abs in HIT patients.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Ethanolamine, ≥98%